CYANOSIS, TRANSIENT NEONATAL
|
disease |
|
Disease or Syndrome
|
1
|
4
|
0.710 |
None |
1.000 |
7 |
4
|
1989 |
2015 |
Blanching of skin
|
phenotype |
|
Sign or Symptom
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Gamma thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1987 |
1987 |
HPFH deletion type
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Central cyanosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Respiratory Tract Diseases; Cardiovascular Diseases
|
Sign or Symptom
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1
|
phenotype |
|
Finding
|
4
|
20
|
0.400 |
None |
1.000 |
1 |
3
|
2015 |
2015 |
Bart's Hemoglobinopathy
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Dominant beta-thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
5
|
2
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Red blood cell disorder
|
group |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Congenital Methemoglobinemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
8
|
0.010 |
None |
1.000 |
1 |
1
|
1972 |
1972 |
Blood Sedimentation
|
phenotype |
|
Laboratory Procedure
|
7
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
NADH cytochrome B5 reductase deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
7
|
45
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Abnormal bone structure
|
disease |
|
Anatomical Abnormality
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Severe beta thalassemia
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
1982 |
1982 |
Persistence of hemoglobin F
|
phenotype |
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
delta beta^0^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
1979 |
1979 |
Mean corpuscular hemoglobin concentration determination
|
phenotype |
|
Laboratory Procedure
|
10
|
19
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Methemoglobinemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
12
|
3
|
0.130 |
None |
0.667 |
3 |
|
2017 |
2019 |
Delta-Beta Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
12
|
|
0.030 |
None |
0.667 |
3 |
|
1982 |
1985 |
Non-infiltrating lobular carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Familial erythrocytosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.010 |
None |
1.000 |
1 |
|
1972 |
1972 |
Homozygous alpha thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Oliguria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
1977 |
1977 |
Hemoglobin F Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
27
|
|
0.400 |
None |
1.000 |
37 |
|
1982 |
2019 |
response to SSRI
|
phenotype |
|
Cell Function
|
28
|
53
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |